Search Results 1061-1070 of 7452 for fsa eligible items on amazon

  1. Obinutuzumab With Or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, Or Combination Chemotherapy In Treating Patients With Relapsed Or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. Radiation Therapy With Durvalumab Or Cetuximab To Treat Patients With Locoregionally Advanced Head And Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Dose-ranging Study Of Orvepitant In Patients With Chronic Refractory Cough - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. A Study Of Using Mesenchymal Stem Cells Developed From The Patients Own Fat Tissue For Reducing Hemodialysis Arteriovenous Fistula Failure - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Phase 2 Efficacy, Safety, And Tolerability Study Of Natalizumab In Focal Epilepsy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  7. Testing The Addition Of Abemaciclib To Olaparib For Women With Recurrent Ovarian Cancer - Mayo Clinic

    Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. Participation eligibility. Participant eligibility includes ...

  8. An Efficacy, Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of BIIB067 In Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study To Learn About Study Medicine Called PF-08049820 In People With Eczema - Mayo Clinic

    Do not have a suitable prescribed medicine for AD; 4. Are considered by their doctors to have moderate to severe AD. Eligible participants will take either PF- ...

  10. Reduced Craniospinal Radiation Therapy And Chemotherapy In Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

    Participation eligibility · classical histologic type (non LC/A) WNT medulloblastoma; · positive nuclear β-catenin by IHC; · positive for CTNNB1 mutation; ...